The DUSP26 phosphatase activator adenylate kinase 2 regulates FADD phosphorylation and cell growth

Nature Communications

Volumn 5, Issue , 2014, Pages

  Kim, Hyunjoo ^a   Lee, Ho June ^b   Oh, Yumin ^a   Choi, Seon Guk ^a   Hong, Se Hoon ^a   Kim, Hyo Jin ^b   Lee, Song Yi ^a   Choi, Ji Woo ^c   Su Hwang, Deog ^a   Kim, Key Sun ^c   Kim, Hyo Joon ^d   Zhang, Jianke ^e   Youn, Hyun Jo ^f   Noh, Dong Young ^g   Jung, Yong Keun ^a  

^a Seoul National University   (South Korea)

^b GENENTECH INC   (United States)

^c Korea Institute of Science and Technology   (South Korea)

^d Hanyang University   (South Korea)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f Chonbuk National University Medical School   (South Korea)

^g Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADENYLATE KINASE 2; DUAL SPECIFICITY PHOSPHATASE; DUSP26 PROTEIN, HUMAN; FADD PROTEIN, HUMAN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE;

ANIMAL; CELL LINE; CELL PROLIFERATION; DRUG SCREENING; GENETICS; HELA CELL LINE; HUMAN; IN VITRO STUDY; MALE; MCF 7 CELL LINE; METABOLISM; MOUSE; NUDE MOUSE; PHOSPHORYLATION; PHYSIOLOGY; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADENYLATE KINASE; ANIMALS; CELL LINE; CELL PROLIFERATION; DUAL-SPECIFICITY PHOSPHATASES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HELA CELLS; HUMANS; IN VITRO TECHNIQUES; MALE; MCF-7 CELLS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASES; PHOSPHORYLATION; TANDEM MASS SPECTROMETRY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84894597311     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4351     Document Type: Article

References (47)

1. Dzeja, P. P., Zelenznikar, R. J. & Goldberg, N. D. Adenylate kinase: kinetic behaviour in intact cells indicates it is integral to multiple cellular processes. Mol. Cell. Biochem. 184, 169-182 (1998). (Pubitemid 28398608)
2. Lee, Y. et al. Cloning and expression of human adenylate kinase 2 isozymes: Differential expression of adenylate kinase 1 and 2 in human muscle tissues. J. Biochem. 123, 47-54 (1998). (Pubitemid 28068564)
3. Dzeja, P. & Terzic, A. Adenylate kinase and AMP signaling networks: Metabolic monitoring, signal communication and body energy sensing. Int. J. Mol. Sci. 10, 1729-1772 (2009).
4. Villa, H. et al. Molecular and Functional characterization of adenylate kinase 2 gene from Leishmania donovani. Eur. J. Biochem. 270, 4339-4347 (2003). (Pubitemid 37340352)
5. Lee, H. J. et al. AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10. Nat. Cell Biol 9, 1303-1310 (2007).
6. Mather, M. & Rottenberg, H. Polycations induce the release of soluble intermembrane mitochondrial proteins. Biochim. Biophys. Acta 1503, 357-368 (2001).
7. Lagresle-Peyrou, C. et al. Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness. Nat. Genet. 41, 106-111 (2009).
8. Pannicke, U. et al. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nat. Genet. 41, 101-105 (2009).
9. Fukada, K., Zhang, F., Vien, A., Cashman, N. R. & Zhu, H. Mitochondrial proteomic analysis of a cell line model of familial amyotrophic lateral sclerosis. Mol. Cell. Proteomics 3, 1211-1223 (2004).
10. Martin, D. N. et al. Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One 4, 2 (2009).
11. Lam, Y. W. et al. Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells. PLoS One 5, 2 (2010).
12. Liu, X., Zhang, M., Go, V. L. & Hu, S. Membrane proteomic analysis of pancreatic cancer cells. J. Biomed. Sci. 17, 74 (2010).
13. Patterson, K. I., Brummer, T., O'Brien, P. M. & Daly, R. J. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem. J. 418, 475-489 (2009).
14. Vasudevan, S. A. et al. MKP-8, a novel MAPK phosphatase that inhibits p38 kinase. Biochem. Biophys. Res. Commun. 330, 511-518 (2005). (Pubitemid 40417674)
15. Hu, Y. & Mivechi, N. F. Association and regulation of heat shock transcription factor 4b with both extracellular signal-regulated kinase mitogen-activated protein kinase and dual-specificity tyrosine phosphatase DUSP26. Mol. Cell. Biol. 26, 3282-3294 (2006).
16. Takagaki, K. et al. Characterization of a novel low-molecular-mass dual specificity phosphatase-4 (LDP-4) expressed in brain. Mol. Cell. Biochem. 296, 177-184 (2007).
17. Yu, W. et al. A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity. Oncogene 26, 1178-1187 (2007).
18. Tanuma, N. et al. Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion. Oncogene 28, 752-761 (2009).
19. Shang, X. et al. Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma. Oncogene 29, 4938-4946 (2010).
20. Wang, J. Y., Lin, C. H., Yang, C. H., Tan, T. H. & Chen, Y. R. Biochemical and biological characterization of a neuroendocrine-associated phosphatase. J. Neurochem. 98, 89-101 (2006).
21. Wang, J. Y., Yang, C. H., Yeh, C. L., Lin, C. H. & Chen, Y. R. NEAP causes down-regulation of EGFR, subsequently induces the suppression of NGF-induced differentiation in PC12 cells. J. Neurochem. 107, 1544-1555 (2008).
22. Emmert-Buck, M. R. et al. Allelic Loss on Chromosome 8p12-21 in Microdissected Prostatic Intraepithelial Neoplasia. Cancer Res. 55, 2959-2962 (1995).
23. Pribill, I. et al. High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinoma. Cancer Genet. Cytogenet. 129, 23-29 (2001). (Pubitemid 32743374)
24. Armes, J. E. et al. Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers. Oncogene 23, 5697-5702 (2004). (Pubitemid 39093049)
25. Chinnaiyan, A. M., O'Rourke, K., Tewari, M. & Dixit, V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512 (1995).
26. Wang, L., Du, F. & Wang, X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133, 693-703 (2008). (Pubitemid 351636305)
27. Yeh, W. C. et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 1954-1958 (1998).
28. Zhang, J., Cado, D., Chen, A., Kabra, N. H. & Winoto, A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392, 296-300 (1998).
29. Zhang, Y. et al. Conditional Fas-associated death domain protein (FADD): GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis. J. Immunol. 175, 3033-3044 (2005). (Pubitemid 41170522)
30. Werner, M. H., Wu, C. & Walsh, C. M. Emerging roles for the death adaptor FADD in death receptor avidity and cell cycle regulation. Cell Cycle 5, 2332-2338 (2006). (Pubitemid 44785841)
31. Osborn, S. L., Sohn, S. J. & Winoto, A. Constitutive phosphorylation mutation in Fas-associated death domain (FADD) results in early cell cycle defects. J. Biol. Chem. 282, 22786-22792 (2007). (Pubitemid 47267372)
32. Chen, G. et al. Phosphorylated FADD induces NF-kB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. Proc. Natl Acad. Sci. USA 102, 12507-12512 (2005). (Pubitemid 41266389)
33. Scaffidi, C. et al. Phosphorylation of FADD/MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase. J. Immunol. 164, 1236-1242 (2000). (Pubitemid 30067235)
34. Hua, Z. C., Sohn, S. J., Kang, C., Cado, D. & Winoto, A. A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region. Immunity 18, 513-521 (2003). (Pubitemid 36513633)
35. Meng, X. W. et al. Central role of Fas-associated death domain protein in apoptosis induction by the mitogen-activated protein kinase kinase inhibitor CI-1040 (PD184352) in acute lymphocytic leukemia cells in vitro. J. Biol. Chem. 278, 47326-47339 (2003). (Pubitemid 37452322)
36. Curtin, J. F. & Cotter, T. G. JNK regulates HIPK3 expression and promotes resistance to Fas-mediated apoptosis in DU 145 prostate carcinoma cells. J. Biol. Chem. 279, 17090-17100 (2004). (Pubitemid 38560465)
37. Matsumura, Y. et al. Phosphorylation status of Fas-associated death domain-containing protein regulates telomerase activity and strongly correlates with prostate cacner outcomes. Pathobiology 76, 293-302 (2009).
38. Amit, S. & Ben-Neriah, Y. NF-kappaB activation in cancer: a challenge for uniquitination-and proteasome-based therapeutic approach. Semin. Cancer Biol. 13, 15-28 (2003). (Pubitemid 36269177)
39. Jang, M. S., Lee, S. J., Kim, C. J., Lee, C. W. & Kim, E. Phosphorylation by pololike kinase 1 induces the tumor-suppressing activity of FADD. Oncogene 30, 471-481 (2011).
40. Rochat-Steiner, V. et al. FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation. J. Exp. Med. 192, 1165-1174 (2000).
41. de Thonel, A., Berraieb, A., Jean, C., Laurent, G. & Quillet-Mary, A. Role of protein kinase C z isoform in Fas resistance of immature myeloid KG1a leukemic cells. Blood 16, 2756-2763 (2001).
42. Alappat, E. C. et al. Phosphorylation of FADD at serine 194 by CKIa regulates its nonapoptotic activities. Mol. Cell 19, 321-332 (2005). (Pubitemid 41074888)
43. Song, M. et al. NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26). Biochem. Biophys. Res. Commun. 381, 491-495 (2009).
44. Song, S. et al. E2-25K/Hip-2 regulates caspase-12 in ER stress-mediated Abeta neurotoxicity. J. Cell. Biol. 182, 675-684 (2008).
45. Screaton, R. A. et al. Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: A poteintial link between genome surveillance and apoptosis. Proc. Natl Acad. Sci. USA 100, 5211-5216 (2003). (Pubitemid 36542684)
46. Gómez-Angelats, M. & Cidlowski, J. A. Molecular evidence for the nuclear localization of FADD. Cell. Death Differ. 10, 791-797 (2003). (Pubitemid 36850240)
47. Alappat, E. C., Volkland, J. & Peter, M. E. Cell cycle effects by C-FADD depend on its C-terminal phosphorylation site. J. Biol. Chem. 278, 41585-41588 (2003). (Pubitemid 37310412)